Blood group isoantibody stimulation in man by feeding blood group-active bacteria.
about
Transplantation tolerance and its outcome during infections and inflammationThe red meat allergy syndrome in SwedenGut microbiota elicits a protective immune response against malaria transmissionInteraction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human floraCarbohydrates as allergens.Determinants of food allergy.Innate immune lectins kill bacteria expressing blood group antigen.Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions.Naturally occurring anti-i/I cold agglutinins may be encoded by different VH3 genes as well as the VH4.21 gene segmentNovel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid.Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tractHeteroimmunization to the capsular polysaccharide of Haemophilus influenzae type b induced by enteric cross-reacting bacteria.Endotoxin-binding substances from human leukocytes and plateletsMicrobial glycan microarrays define key features of host-microbial interactions.Immunological considerations for embryonic and induced pluripotent stem cell banking.Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation.Identification and characterization of endogenous galectins expressed in Madin Darby canine kidney cells.On the dark side of therapies with immunoglobulin concentrates: the adverse eventsLate antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis.Enteric bacterial agents and the ABO blood groups.Manipulation of the glycan-specific natural antibody repertoire for immunotherapyB Cells, Antibodies, and More.Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens.Immunogenicity of pluripotent stem cells and their derivativesDiversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for diseaseB cells in transplantation.The effect of complement depletion on lung clearance of bacteria.Improved serodiagnosis of Salmonella enteric fevers by an enzyme-linked immunosorbent assay.The Tn antigen-structural simplicity and biological complexity.Antibodies and ABO-incompatibility in pediatric transplantation.Initiation and regulation of complement during hemolytic transfusion reactions.Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.Dual specificity of human plasma lactose-binding immunoglobulin to anomers of terminal galactose enables recognition of desialylated lipoprotein(a) and xenoantigens.Adsorption of chain type-specific ABO antibodies on Sepharose-linked A and B tetrasaccharides.Induction of cytolytic anti-Gal antibodies in alpha-1,3-galactosyltransferase gene knockout mice by oral inoculation with Escherichia coli O86:B7 bacteria.Anti-A and anti-B: what are they and where do they come from?Strategies to overcome the ABO barrier in kidney transplantation.Innate immunity against molecular mimicry: Examining galectin-mediated antimicrobial activity.ABO-incompatible heart transplantation.Effect of carbamylation of lysine epsilon-amino groups on the activity of blood group specific glycoproteins.
P2860
Q26829817-C3D367EE-2D2E-459D-84D2-766AC3BE9B8EQ28074633-F2A244DD-026A-4241-869A-804029E0670DQ28253398-523FA0D0-E2BC-4C49-B7D5-F3D326C7E92CQ28361310-5D411825-C4D7-4201-81B5-E62743CB1AE4Q30301262-43E9D83A-51F7-43C7-8662-290A0C63001DQ30422603-BD195308-A828-4342-8D25-396FC0D280E3Q30494049-03342797-1406-49E2-BCA7-C00E67B36945Q33157418-C4D12F5E-E4FF-472D-885C-776DFAA77498Q33910016-BCE71DB9-F164-4DFF-8A0A-CF303BC60006Q34044438-6F3761CC-1C91-4A6A-85FB-0A67A1BB41CFQ34105660-A737967E-2CD4-4979-8D44-667DDC5764C9Q34120272-D86AA389-A933-4957-A021-D27C8FCDEA54Q34129800-79DA5D7C-8980-465C-B7DC-34B357EB4C74Q34154041-E2063555-44A8-49A0-983D-F4EC5E11AE53Q34197332-D29BCBFE-6320-44C0-9240-5DF73F27860BQ34361643-066A51ED-307D-4836-9DDE-81B148FAE838Q34675709-F4C90C68-06A0-44F5-9CE3-DD6EE225EA8AQ35053458-A3E68798-D0A1-488C-A115-9E97036E7C72Q35092009-148F57B2-1F1F-48BD-9717-D8E5D6A73596Q35232439-58D3AA92-3B1E-4D65-B97C-509A0A1B3C48Q35920081-EE07A61A-780C-40BC-869C-7E1EAD86F7CCQ36432935-1DE9C393-B14D-48E3-94E2-CA229B9FEFA1Q36741513-6BF669A7-6C1A-4615-BE4C-09789B288E70Q36802900-5D4A2976-B512-4C90-AA65-76711CC0547EQ36981219-E9AC50F3-D27C-45EE-B8E7-035157538C07Q37029874-16144552-0896-44BC-A224-2C43F006B634Q37030806-BD8F8F62-0FC0-4A4F-A2B4-7233FF181C58Q37331837-CCB4F344-47D5-4A00-8668-D73D35C423EDQ37831859-87B5D982-D08C-4A60-9BA5-D0E6588814D1Q37960155-45ED9284-2A37-4B4D-AA80-4DA391FF9920Q38057232-E9A15DDF-1625-4A16-8608-D55C1BC27C8BQ38121846-1A6CFF58-5337-4C48-826D-7E35CFD08560Q38308982-C0A48F14-90AC-41BC-9EA2-76BC73582B8AQ38325273-F0E60A05-97C4-487A-9C88-71BDF63F9912Q38361951-3B8AC6E1-38A5-4A3A-963E-F304854667A3Q38547193-21E69F77-E7AA-4672-B508-EC2C91C8BD9BQ38577657-9E89315B-6B50-4D86-8246-E215EFB9ACC8Q38635983-6651762F-A289-44D3-9D28-CE9FEBC56C33Q38845138-571EA5C2-5AE3-48D6-BEB5-AE8E2363844AQ39375656-D081A607-B792-42A9-ACC2-D1E57DD52735
P2860
Blood group isoantibody stimulation in man by feeding blood group-active bacteria.
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年論文
@yue
1969年論文
@zh-hant
1969年論文
@zh-hk
1969年論文
@zh-mo
1969年論文
@zh-tw
1969年论文
@wuu
1969年论文
@zh
1969年论文
@zh-cn
name
Blood group isoantibody stimulation in man by feeding blood group-active bacteria.
@ast
Blood group isoantibody stimulation in man by feeding blood group-active bacteria.
@en
type
label
Blood group isoantibody stimulation in man by feeding blood group-active bacteria.
@ast
Blood group isoantibody stimulation in man by feeding blood group-active bacteria.
@en
prefLabel
Blood group isoantibody stimulation in man by feeding blood group-active bacteria.
@ast
Blood group isoantibody stimulation in man by feeding blood group-active bacteria.
@en
P2860
P356
P1476
Blood group isoantibody stimulation in man by feeding blood group-active bacteria.
@en
P2093
Springer GF
P2860
P304
P356
10.1172/JCI106094
P407
P577
1969-07-01T00:00:00Z